Your browser doesn't support javascript.
loading
Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel.
Pegna, Guillaume Joe; Lee, Min-Jung; Peer, Cody J; Ahmad, Mehwish I; Venzon, David J; Yu, Yunkai; Yuno, Akira; Steinberg, Seth M; Cao, Liang; Figg, William D; Donahue, Renee N; Hassan, Raffit; Pastan, Ira; Trepel, Jane B; Alewine, Christine.
Afiliación
  • Pegna GJ; Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Lee MJ; Medical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Peer CJ; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
  • Ahmad MI; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Venzon DJ; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Yu Y; Office of Research Nursing, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Yuno A; Astra Zeneca, Gaithersburg, Maryland, USA.
  • Steinberg SM; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Cao L; Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Figg WD; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Donahue RN; Oral and Maxillofacial Surgery, Kumamoto University Hospital, Kumamoto, Japan.
  • Hassan R; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Pastan I; Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Trepel JB; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Alewine C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Cancer Med ; 12(4): 4236-4249, 2023 02.
Article en En | MEDLINE | ID: mdl-36208017
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunotoxinas / Inmunoconjugados Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunotoxinas / Inmunoconjugados Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos